This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,411 Years Active: 2001
Title: The Innovations of Sophie Gafvert
Introduction
Sophie Gafvert is a notable inventor based in Enhorna, Sweden. She has made significant contributions to the field of veterinary medicine, particularly in the identification of genetic conditions in dogs. Her work has implications for both animal health and breeding practices.
Latest Patents
Sophie Gafvert holds a patent for her invention titled "Identification of canine leukocyte adhesion deficiency in dogs." This patent involves an isolated nucleic acid molecule that encodes the canine leukocyte integrin β-2 subunit, which has a Cys36Ser missense mutation. This mutation is indicative of a carrier of canine leukocyte adhesion deficiency. The invention also outlines a method for identifying dogs that are carriers or affected by this condition, which includes obtaining a biological sample and testing for the specific mutation.
Career Highlights
Throughout her career, Sophie has focused on advancing veterinary genetics. Her innovative approach has led to a better understanding of canine health issues, particularly those related to genetic disorders. She has successfully navigated the complexities of patenting her work, ensuring that her contributions are recognized and protected.
Collaborations
Sophie has collaborated with esteemed colleagues in her field, including Leif H Andersson and James Kijas. These partnerships have enhanced her research and expanded the impact of her inventions.
Conclusion
Sophie Gafvert's work exemplifies the intersection of innovation and veterinary science. Her patent on canine leukocyte adhesion deficiency is a testament to her dedication to improving animal health. Through her research and collaborations, she continues to make a significant impact in her field.